Ad
CUR Short Information Neuralstem Inc.
Short Information | Neuralstem Inc. (NASDAQ:CUR)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 507,176 |
| Total Actual Volume | 2,521,643 |
| Short Trends | |
|---|---|
| Cover Days | 19 |
| Short Days | 0 |
| No Change Days | 1 |
| Averages | |
|---|---|
| Average Short Volume | 25,359 |
| Average Short Percentage | 21.21% |
Is there a CUR Short Squeeze or Breakout about to happen?
See the CUR Short Analysis for free Sign up or Login
Powered by Squeeze Report
CUR Twenty Trading Day's Volume to Short Volume Chart
CUR Twenty Trading Day Price Chart
CUR Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 10-17-2019 | $1.24 | $1.29 | $1.29 | $1.20 | 78,429 | 18,355 | 23.4% |
| 10-16-2019 | $1.36 | $1.32 | $1.66 | $1.25 | 883,783 | 159,869 | 18.09% |
| 10-15-2019 | $1.29 | $1.35 | $1.40 | $1.23 | 101,489 | 24,814 | 24.45% |
| 10-14-2019 | $1.30 | $1.30 | $1.35 | $1.22 | 169,150 | 23,940 | 14.15% |
| 10-11-2019 | $1.22 | $1.15 | $1.30 | $1.1414 | 138,300 | 31,250 | 22.6% |
| 10-10-2019 | $1.21 | $1.21 | $1.25 | $1.19 | 16,832 | 1,707 | 10.14% |
| 10-09-2019 | $1.28 | $1.22 | $1.30 | $1.10 | 70,035 | 9,270 | 13.24% |
| 10-08-2019 | $1.35 | $1.28 | $1.37 | $1.22 | 86,448 | 12,924 | 14.95% |
| 10-07-2019 | $1.40 | $1.37 | $1.45 | $1.32 | 41,235 | 14,004 | 33.96% |
| 10-04-2019 | $1.47 | $1.41 | $1.52 | $1.28 | 112,756 | 15,350 | 13.61% |
| 10-03-2019 | $1.61 | $1.45 | $1.64 | $1.41 | 82,980 | 17,520 | 21.11% |
| 10-02-2019 | $1.67 | $1.60 | $1.68 | $1.56 | 68,510 | 10,609 | 15.49% |
| 10-01-2019 | $1.66 | $1.69 | $1.75 | $1.63 | 108,141 | 38,426 | 35.53% |
| 09-30-2019 | $1.68 | $1.67 | $1.71 | $1.62 | 46,698 | 15,806 | 33.85% |
| 09-27-2019 | $1.63 | $1.68 | $1.72 | $1.62 | 31,140 | 2,364 | 7.59% |
| 09-26-2019 | $1.60 | $1.68 | $1.69 | $1.57 | 33,530 | 7,315 | 21.82% |
| 09-25-2019 | $1.61 | $1.62 | $1.68 | $1.55 | 70,361 | 21,928 | 31.16% |
| 09-24-2019 | $1.73 | $1.63 | $1.78 | $1.58 | 198,375 | 34,262 | 17.27% |
| 09-23-2019 | $1.69 | $1.70 | $1.81 | $1.57 | 114,961 | 29,758 | 25.89% |
| 09-20-2019 | $1.69 | $1.69 | $1.7355 | $1.57 | 68,490 | 17,705 | 25.85% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled ZYESAMI™ in the treatment of moderate and severe COVID-19 (AVICOVID-2) was dosed at the University of California Irvine. The trial will be conducted at 10-15 clinica...
-
GERMANTOWN, Md. , Sept. 2, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today provided the following letter from Dr. Ken Carter , the Company's Executive Chairm...
-
GERMANTOWN, Md. , May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced the closing of its previously announced $5 million registered...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...